É. Billard

发表

Discovery of New Allosteric Modulators of the Urotensinergic System through Substitution of the Urotensin II-Related Peptide (URP) Phenylalanine Residue.

T. Hébert, D. Chatenet, É. Billard, 2018, Journal of medicinal chemistry.

Insight into the role of urotensin II‐related peptide tyrosine residue in UT activation

T. Hébert, M. Létourneau, D. Chatenet, 2017, Biochemical pharmacology.

Urotensin core mimics that modulate the biological activity of urotensin-II related peptide but not urotensin-II.

W. Lubell, D. Chatenet, É. Billard, 2017, Bioorganic & medicinal chemistry letters.

Urotensin II((4-11)) Azasulfuryl Peptides: Synthesis and Biological Activity.

P. Grieco, F. Merlino, W. Lubell, 2016, Journal of medicinal chemistry.

Design, Synthesis, and Biological Assessment of Biased Allosteric Modulation of the Urotensin II Receptor Using Achiral 1,3,4-Benzotriazepin-2-one Turn Mimics.

T. Hébert, W. Lubell, D. Chatenet, 2017, Journal of medicinal chemistry.

Insights into the Molecular Determinants Involved in Urocontrin and Urocontrin A Action.

D. Chatenet, É. Billard, 2020, ACS medicinal chemistry letters.

Functional Selectivity Revealed by N-Methylation Scanning of Human Urotensin II and Related Peptides.

E. Novellino, P. Grieco, D. Brancaccio, 2019, Journal of medicinal chemistry.

Design of a peptidic inhibitor that targets the dimer interface of a prototypic galectin

D. Gagné, N. Doucet, Y. St-Pierre, 2015, Oncotarget.

Unnatural amino acids improve affinity and modulate immunogenicity: Developing peptides to treat MHC type II autoimmune disorders

John F. Trant, D. Chatenet, S. Taimoory, 2019 .

Lipidated peptides derived from intracellular loops 2 and 3 of the urotensin II receptor act as biased allosteric ligands

E. Novellino, A. Carotenuto, J. Tanny, 2021, The Journal of biological chemistry.

Membrane-tethered peptides derived from intracellular loops 2 and 3 of the urotensin II receptor act as allosteric biased ligands

E. Novellino, A. Carotenuto, J. Tanny, 2020, bioRxiv.

EXPLORATION OF THE UROCONTRIN A SCAFFOLD YIELDS NEW UROTENSINERGIC SYSTEM ALLOSTERIC MODULATOR AND COMPETITIVE ANTAGONISTS.

D. Chatenet, É. Billard, Terence E. Hébert, 2023, Biochemical pharmacology.

Design of a peptidic inhibitor that targets the dimer interface of a prototypic galectin

D. Gagné, N. Doucet, Y. St-Pierre, 2015, Oncotarget.

Evidence for heterodimerization and functional interaction of the urotensin II and the angiotensin II type 1 receptors.

D. Devost, D. Chatenet, É. Billard, 2024, Cellular signalling.

P(VDF-TrFE) Copolymer Thin Films for Pyroelectric Applications

V. Bornand, P. Papet, É. Billard, 2008 .